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Human metapneumovirus (HMPV) is a newly discov-
ered pathogen thought to be associated with respiratory
disease. We report the results of a study of 587 children
hospitalized with respiratory infection over a 13-month peri-
od. HMPV was detected in the nasopharyngeal aspirates
from 32 (5.5%) children by reverse transcription-poly-
merase chain reaction. HMPV infection was associated
with clinical diagnoses of pneumonia (36%), asthma exac-
erbation (23%), or acute bronchiolitis (10%). When com-
pared to those with respiratory syncytial virus infection, chil-
dren with HMPV infection were older, and wheezing was
more likely to represent asthma exacerbation rather than
acute bronchiolitis. HMPV viral activity peaked during the
spring-summer period in Hong Kong. Phylogenetically, all
HMPV virus strains from Hong Kong belonged to one of the
two genetic lineages previously described. HMPV con-
tributed to 441.6 hospital admissions per 100,000 popula-
tion <6 years of age. 
G
lobally, respiratory infections in childhood are a lead-
ing cause of disease, contributing to absenteeism and
economic strain through use of healthcare resources (1). In
the developing world, respiratory infections are also a
major cause of childhood death, although the contribution
of viruses to such deaths is unclear (2). Respiratory syncy-
tial virus (RSV) and influenza are recognized as important
contributors to hospitalization (3–5). Despite sensitive
diagnostic methods, an etiologic agent still cannot be iden-
tified in a portion of children with acute respiratory infec-
tion (6). Human metapneumovirus (HMPV) is a recently
discovered respiratory virus belonging to the family
Paramyxovidiridae (7,8), and its clinical significance is
still being defined. After its initial discovery in the
Netherlands, HMPV has been detected in respiratory spec-
imens from patients of all ages in a number of countries,
e.g., Canada, Australia, United Kingdom, and Finland
(9–14).In children, HMPV has been reported to cause dis-
ease similar to that of RSV; signs and symptoms range
from severe cough to bronchiolitis and pneumonia.
However, a detailed analysis of clinical signs in children is
lacking. Furthermore, HMPV has not been reported in
tropical or subtropical regions. Routine immunization of
children against influenza is now under active considera-
tion by the Advisory Committee on Immunization
Practices, and vaccines for RSV are being developed.
Therefore, defining the role of the newly emerging HMPV
is important in childhood respiratory disease. 
Materials and Methods
Study Design
The Hong Kong Special Administrative Region is
located within the tropics but has a subtropical climate.
Within this region of Hong Kong Island are 288,371 per-
sons <18 years of age and 84,018 <6 years of age (based
on 2001 Census data). Two publicly funded hospitals of
the Hospital Authority of Hong Kong, Queen Mary
Hospital and Pamela Youde Nethersole Eastern Hospital,
provide 90% of all acute pediatric hospital care (admission
ratio 1:1.65). At Queen Mary Hospital, a nasopharyngeal
aspirate is routinely collected for viral investigation from
all children hospitalized with acute respiratory disease. 
We investigated a systematic sample of children (<18
years of age) admitted with acute respiratory infection to
Queen Mary Hospital during a 13-month period. From
August 2001 to March 2002, all children admitted to
Queen Mary Hospital with symptoms of respiratory infec-
tion on one fixed day each week were included in this
study of HMPV infection. From April through August
2002, study enrollment was increased to twice weekly.
The results of virologic diagnosis of HMPV were not
available to the attending pediatricians. The clinical fea-
tures of children identified to have HMPV infection were
compared with age-matched controls with influenza A or
RSV infection. 
Viral Diagnosis
Nasopharyngeal aspirates from patients were tested for
RSV, influenza A and B, adenovirus, and parainfluenza
types 1, 2, and 3 by culture and immunofluorescent antigen
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SAR, Chinadetection as previously described (15,16). An aliquot of
these aspirates was snap-frozen for testing for HMPV.
Viral RNAwere extracted by using the RNAeasy kit (QIA-
GEN GmbH, Hilden, Germany) and tested by reverse tran-
scription-polymerase chain reaction (RT-PCR) with
primers to the viral L gene as previously described (7). All
positive results were confirmed by retesting with a nested
RT-PCR with primers to regions of the M gene conserved
between HMPV and avian pneumovirus(8). 
Twelve microliters of viral RNA was amplified in 20
µL volumes containing the following components: 2 mM
Tris-HCL (pH7.5), 10 mM NaCL, 0.01 mM EDTA, 0.11
mM DTT, 0.001% NP-40, 0.5 mM each of the four
deoxynucleotide triphosphates, 7.5 ng random primers
(Invitrogen, Life Technology, Carlsbad, CA), and 20 U of
Superscript II Rnase H- Reverse Transcriptase (Invitrogen,
Life Technology). The reactions were allowed to proceed
in a thermocycler programmed to incubate for 50 min at
42°C and 3 min at 94°C cycler (Perkin-Elmer Cetus,
Gouda, the Netherlands). Five microliters of cDNA was
used for PCR amplification reaction with 0.5 µM of two
primers (sense 5′-CATGCCCACTATAAAAGGTCAG-3′
and anti-sense 5′-CACCCCAGTCTTTCTTGAAA-3′),
corresponding to the sequence of the L gene of metapneu-
movirus. Samples were amplified by heating at 95°C for
12 min, 30 cycles of 94°C for 1 min, 60°C for 1 min, 72°C
for 1 min, and a final of extension period of 7 min at 72°C.
Similarly, 5 µL of cDNAwas used for a first PCR amplifi-
cation reaction with 0.5 µM of two degenerated primers
(sense 5′-AARGTSAATGCATCAGC-3′ and anti-sense 5′-
CAKATTYTGCTTATGCTTTC-3′), corresponding to the
sequence of the matrix gene of metapneumovirus, which
can detect both avian and human metapneumovirus.
Samples were amplified in similar reaction mixture previ-
ously described by heating at 95°C for 12 min, 30 cycles
of 94°C for 30 s, 60°C for 30 s, 72°C for 1 min, and a final
of extension period of 7 min at 72°C. A5-µL aliquot of the
first PCR product was transferred into a second PCR tube
for nested PCR by using two inner specific M gene primers
for HMPV (5′-ACACCTGTTACAATACCAGC-3′ and 5′-
GACTTGAGTCCCAGCTCCA-3′). The reaction mixture
was subjected to a further 95°C, 12 min, 30 cycles of 94°C,
55°C, and 72°C for 1 min each, and a final of extension
period of 7 min at 72°C. PCR products were analyzed by
electrophoresis in a 2% (w/v) agarose gel and stained with
0.5 µg/mL of ethidium bromide. The sizes of L gene and
M gene nested PCR products were 171 bp and 201 bp,
respectively. Only specimens with a positive result for
both tests were regarded as confirmed positive.
The 171-bp fragment of the RT-PCR–amplified product
of the viral L gene was sequenced for phylogenetic analy-
sis. The PCR-amplified DNA was sequenced by using the
Big Dye Terminator Cycle Sequencing Ready Reaction kit
(Applied Biosystems, Foster City, CA). Briefly, PCR prod-
ucts were purified by using the QIA quick PCR
Purification Kit (QIAGEN GmbH) according to manufac-
turer’s instruction. A total of 35 to 50 ng of purified PCR
products were mixed with two tubes containing 1.6 pmol
(forward and reverse), 4 µL Terminator reaction mix (con-
taining deoxy- and dideoxy-nucleotides, and modified Taq
polymerase), and made up to a final volume of 10 µL with
MilliQ water. Cycle sequencing was performed in the ther-
mocyler with profile consisted of a 96°C denaturation step
for 30 s, followed by an annealing temperature of 50°C for
15 s and extension temperature of 60°C for 4 min, for a
total of 25 cycles. Unincorporated dye terminators and
nucleotides were removed by using the DyeEx kit (QIA-
GEN GmbH). The procedure was performed according to
the user manual of the package. The DNA template was
denatured at 94°C for 4 min and stored in ice, ready for
sequencing on a Perkin-Elmer 377 XL DNA sequencer
(Applied Biosystems). DNA sequences were aligned by
using the Clustal X software, and phylogenetic analysis
was conducted by using MEGA (v. 2.1, Arizona State
University, Temple, AZ). The distances for the multiple
aligned DNA sequences were estimated by using the
Jukes-Cantor method and a phylogenetic tree constructed
by using neighbor-joining method. The tree was subjected
to bootstrap test (100 replicates) and bootstrap values >40
are shown.
Chart and Radiographic Review
All medical records were reviewed by a pediatrician
(S.S.C.). At the end of the study, the chest radiographs
were reviewed by a pediatric radiologist (P.L.K.), who
knew that these children had a cough and febrile illness but
did not know the clinical or microbiologic diagnoses. 
Results
Epidemiology
Since obtaining an nasopharyngeal aspirates to test for
common respiratory viruses is a routine diagnostic proce-
dure, all children with acute respiratory symptoms admit-
ted on the study days were enrolled. Atotal of 587 patients
were studied; 302 were enrolled in the first 7 months of the
study with patients being admitted on one fixed day of
each week. Another 285 patients were enrolled during the
last 6 months, with patients admitted on two fixed days of
the week recruited to the study. The study sample repre-
sented 15.5% of all 3,787 acute pediatric admissions to
Queen Mary Hospital and 22.9% of all 2,563 admissions
for acute respiratory disease. Thirty-two (5.5%) children
had HMPV virus RNA detected in the nasopharyngeal
aspirate specimen when tested by RT-PCR. In comparison,
routine immunofluorescent antigen detection and viral cul-
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19.50 ± 17.24 months), 8% had influenza Aor B (mean age
30.23 ± 22.61 months), 5% had parainfluenza (mean age
37.75 ± 36.87 months), and 3.1% had adenovirus infec-
tions (mean age 44.11 ± 53.22 months). Children with
HMPV ranged from 3 months to 72 months of age (mean
31.7 ± 18.7 months) and were older than those with RSV
infection (p=0.004). The preponderance of males (M:F
3:1) with HMPV was greater than that of the study group
overall (M:F 1.2:1) (p=0.03). The peak of HMPV activity
occurred in spring and the early summer months in
2001–02 in Hong Kong (Figure 1). The seasonality of
other common respiratory viruses during the study period
based on viral diagnoses of all children admitted with res-
piratory infections to Queen Mary Hospital showed that
RSV had a similar seasonality as HMPV (Figure 2). Two
children with HMPV disease had co-infection: one with
adenovirus and another with influenza A. No other chil-
dren had a viral co-infection.
During the first 12 months of the study, 2,563 persons
were admitted for acute respiratory infections to Queen
Mary Hospital. From the monthly HMPV isolation rate in
our representative sample, we calculated the total of
HMPV infections admitted to Queen Mary Hospital during
each of the first 12 study months. We estimated that 126
children were hospitalized with HMPV during this period.
On average, the ratio of acute pediatric admissions
between Queen Mary Hospital and Pamela Youde
Nethersole Eastern Hospital is 1:1.65. Since these two hos-
pitals provide 90% of all hospital admissions for Hong
Kong Island, we estimated that 371 persons were admitted
to the hospital with HMPV of 84,018 children <6 years of
age living in Hong Kong Island, resulting in a hospitaliza-
tion rate of 441.6 per 100,000 population <6 years of age.
As the mean duration of hospitalization per episode was
3.17 days (Table 1), we estimated HMPV accounted for
1,176 days of hospitalization per year in children <6 years
of age on Hong Kong Island. 
Clinical and Laboratory Findings
All children (100%) with HMPV had a fever, and 28
(90%) had cough with sputum (Table 1 and 2). Two chil-
dren with HMPV had hoarseness without stridor. Five
(16.1%) children had febrile seizures; two had three
seizures each. Four (12.9%) children with HMPV had a
truncal rash (on the chest only in three) that was blanch-
able, nonpruritic, maculopapular, and transient, lasting for
a few hours to a day. Two children had diarrhea not relat-
ed to antibiotics. Nine (29%) children had lymphopenia
(mean 0.96 ± 0.26 x 109/L), and two children had elevated
transaminases (ALT, AST, and GGT for the two children
were 80 MU/L, 40 MU/L, 77 MU/L, and 339 MU/L, 432
MU/L, 634 MU/L, respectively). Of children with HMPV
infection, 26.3% had one or more adult family contacts
who also had an acute respiratory illness (Table 1).
A72-month-old child with newly diagnosed acute lym-
phoblastic leukemia had documented HMPV infection.
She had very mild coryzal symptoms for 4 days with a
temperature of 38.3°C for a day; and she recovered
uneventfully. Fever, coryza, and diarrhea associated with
HMPV developed in one other child hospitalized for fail-
ure to thrive 6 days after sharing a room for 24 hours with
a child with fever and diarrhea, who was subsequently
diagnosed to have HMPV infection. This incident suggest-
ed a nosocomial transmission with an incubation period for
HMPV disease of 5 to 6 days. 
The clinical characteristics of patients with HMPV
were compared with those of age-matched children with
RSV or influenza A (Table 2). Children infected with
HMPVtended to have a longer duration of fever than those
with RSV, although this finding did not attain statistical
significance. In comparison to RSV and influenza, patients
with HMPV tended to have a longer hospital stay.
However, rapid diagnostic test results for patients with
influenza and RSV might influence their quicker discharge
from hospital (15). Both HMPV and RSV infections were
more likely to be associated with wheezing than were
influenza infections. However, in contrast to RSV infec-
tion, the cause of wheezing in HPMV infection was often
asthma exacerbation rather than acute bronchiolitis.
Asthma exacerbation accounted for 66.7% of the wheezing
of HMPV-infected children but only 16.7% in RSV-infect-
ed children. HMPV was at least as important as influenza
as a cause of febrile seizures.
Radiographic Findings
Children with HMPV were more likely to have requests
for a chest x-ray (Table 2). Independent of specialist radi-
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Figure 1. Number of patients tested and percentage positive for
human metapneumovirus and the seasonality of other common
respiratory viruses during the study period. Data for human metap-
neumovirus are based on a subset of patients admitted to Queen
Mary Hospital (see Methods); data for the other respiratory virus-
es are based on all children admitted. ologic assessment, the attending pediatricians diagnosed
bacterial pneumonia in four, atypical pneumonia in five,
and viral pneumonia in three children, respectively. All
chest x-rays were subsequently reviewed by the pediatric
radiologist. Perihilar peribronchial thickening, perihilar
patchy consolidation, or both were found in 14 patients,
suggesting a viral infection. Viral or atypical pneumonia
was diagnosed in one child, and viral or bacterial pneumo-
nia was diagnosed in two. Hyperinflation was seen in five
children. No child had lobar consolidation. 
Phylogenetic Data
Previous studies have shown two distinct phylogenetic
lineages of HMPV (8). The viruses detected in Hong Kong
during 2002 belonged to one of these lineages (Figure 2).
The viruses from the patients with presumed nosocomial
transmission were genetically identical. 
Discussion
In a representative sample of children hospitalized with
acute respiratory symptoms during a 13-month period, we
found HMPV virus activity in the spring and summer
months. Previous studies, all from temperate regions, have
reported HMPV to be a virus with a winter-spring season-
ality. In contrast to temperate regions, RSV (and some-
times influenza) in Hong Kong also has a spring-summer
seasonality. Surveillance over more years is needed to
establish whether the seasonality of HMPV is a recurrent
pattern. Our estimate of 441.6 HMPV-associated hospital-
izations per 100,000 children <6 years of age annually can
be compared with recent estimates of influenza-related
hospitalization in Hong Kong, which ranged from 2,882
per 100,000 in children <1 year of age to 773 per 100,000
children 2–5 years of age (5).
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Figure 2. Phylogenetic tree of the human metapneumovirus a) L gene and b) F gene. Viruses detected in Hong Kong are prefixed HK,
and the sequences are deposited in GenBank under accession numbers AY294849 through AY294870. Other viral sequences were
obtained from GenBank. Abbreviations used: APV, avian pneumovirus; NL, the Netherlands. 
a bFrom this preliminary report, HMPV appears to be an
important respiratory pathogen in children, causing a
wider spectrum of disease than previously appreciated.
Nine of the 32 patients with HMPV had wheezing, asthma
exacerbation, or bronchiolitis as a symptom.
Approximately one third of patients with HMPV infection
were clinically diagnosed to have pneumonia. Not all
patients had chest x-rays. However, 17 of the 25 patients
who did had abnormalities in their chest x-rays. Thus, a
minimum estimate for radiologic abnormalities in children
hospitalized with HMPV infection was 53%. Influenza has
been previously reported to be a major cause of febrile
seizures (17). We found that HMPV may also be an impor-
tant cause of febrile seizures. In fact, some of the children
had multiple seizures during the same episode of HMPV
infection. Association of HMPV with febrile seizures,
rash, diarrhea, and transaminases has not been previously
reported. HMPV was previously reported to cause severe
lower respiratory disease and death in children with hema-
tologic malignancies (12,14). We documented HMPV in a
child with acute lymphoblastic leukemia, but the illness
was mild and self-limited, possibly because infection
occurred at the time of diagnosis, before any immunosup-
pressive therapy was initiated. 
Over half of the patients with HMPV had an influenza-
like illness reported in one or more of their family contacts
(all ages), while 26% reported an adult family member
with an influenzalike illness. Seroepidemiologic data in
the Netherlands showed that all children are seropositive
for HMPV antibody by 10 years of age (7). Further viro-
logic studies of family contacts may elucidate the role of
household transmission of HMPV. Recurrent infection has
been documented in a few children, and the virus has also
been detected in adults (7,9,11,12,14).
When compared to age-matched children infected with
RSV or influenza, a greater proportion of children with
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Table 1. Fever and duration of hospitalization of 32 children admitted with HMPV with age-matched controls with RSV and influenza A  
HMPV  RSV  Influenza A 
Characteristics  Mean (SD)  Mean (SD)  Mean (SD)  p value
b 
Age (months)  31.70 (18.40)  31.75 (18.41)  31.25 (18.57)  0.99 
Duration of hospitalization (days)  3.17 (1.39)
c  2.81 (1.18)  2.44 (0.96)  0.054 
Highest temperature in hospital (°C)
c  39.20 (0.59)  39.04 (0.54)  39.23 (0.60)  0.44 
Duration of fever  4.53 (2.23)  3.57 (1.83)  4.50 (1.86)  0.12 
aHMPV, human metapneumovirus; RSV, respiratory syncytial virus.
 
bp value performed using the analysis of variance (ANOVA) test. 
cTwo children with HMPV infection were excluded from analysis. A 5-year-old girl newly diagnosed with acute lymphoblastic leukemia had coryzal symptoms and was 
febrile with nasopharyngeal aspirates positive for HMPV on day 2 of admission. Her total hospitalization stay for chemotherapy and Pseudomonas septicemia was 42 
days. A 3-month-old girl was admitted for evaluation of failure to thrive and to gain weight; fever, coryza, and diarrhea developed on day 7 of hospitalization. Her total 
hospitalization of 10 days was also removed from analysis.  
dThis excluded children who were not febrile in the hospital: three children with HMPV, seven with RSV, and four with influenza A. 
Table 2. Characteristics of 32 children admitted with HMPV compared with age-matched controls with RSV and influenza A
a 
HMPV  RSV  Influenza A  p value
b 
Characteristics 
No. positive/ 
total (%) 
No. positive/ 
total (%) 
No. positive/ 
total (%)  Overall 
HMPV vs. 
RSV 
HMPV vs. 
influenza A 
Influenzalike illness in family contact  10/19 (52.6)  7/29 (24.1)  19/24 (79.1)  0.0003  0.29  0.37 
Influenzalike illness in adult family contact  5/19 (26.3)  4/29 (13.8)  13/24 (54.2)  0.005  0.68  0.45 
Febrile seizures  5/32 (15.6)  1/32 (3.1)  3/32 (9.4)  0.229  —  — 
Congested pharynx  12/32 (37.5)  11/32 (34.4)  11/32 (34.4)  0.955  —  — 
Rash  4/32 (12.5)  1/32 (3.1)  4/32 (12.5)  0.331  —  — 
Enlarged liver  2/32 (6.3)  0/32 (0.0)  4/32 (12.5)  0.331  —  — 
Otitis media  4/32 (12.5)  0/32 (0.0)  0/32 (0.0)  0.201  —  — 
Diarrhea  2/32 (6.3)  1/32 (3.1)  3/32 (9.4)  0.586  —  — 
Crepitations  18/32 (56.3)  14/32 (43.8)  3/32 (9.4)  0.0003  0.50  0.0007 
Wheezing  9/32 (28.1)  12/32 (37.5)  2/32 (6.3)  0.0109  0.60  0.04 
Asthma exacerbation  6/32 (18.8)  2/32 (6.3)  2/32 (6.3)  0.167  —  — 
Acute bronchiolitis  3/32 (9.4)  10/32 (31.3)  0/32 (0.0)  0.0009  0.13  0.37 
Pneumonia  12/32 (37.5)  5/32 (15.6)  1/32 (3.1)  0.0017  0.30  0.009 
Abnormal chest x-ray  17/25 (68.0)  11/18 (61.1)  1/17 (5.9)  0.0002  0.89  0.0002 
Lymphopenia (<1.5 x 10
9/L)  9/31 (29.0)  2/27 (7.4)  12/29 (41.4)  0.017  0.34  1.0 
Neutropenia (ANC<1 x 10
9/L)  2/31 (6.5)  0/27 (0.0)  4/29 (13.8)  0.125  —  — 
Elevated transaminases  2/15 (13.3)  0/5 (0.0)  3/11 (27.3)  0.357  —  — 
aHMPV, human metapneumovirus; RSV, respiratory syncytial virus. 
bp values performed using McNemar chi-square test. HMPV infection had lower respiratory tract involvement
leading to more chest x-rays being performed. HMPV
appeared to be a stronger trigger for asthma exacerbation
than RSV or influenza (Table 2). In a recent study of chil-
dren hospitalized with wheezing in Finland, HMPV was
detected in 10 (32%) of 31 children recruited during the
period of peak HMPV activity (January–April) or in 7.5%
of the 132 children overall (13). The chemokine profile
(interleukin 8 and RANTES) in nasal secretions of chil-
dren infected with HMPV was different from that reported
in infections with RSV. 
The role of viral respiratory tract infections in acute and
chronic asthma has been a subject of much research inter-
est. Globally, the prevalence of asthma has increased, and
recent data show that the prevalence of asthma in Hong
Kong children 6–7 years of age is 8% (18). Viruses have
been demonstrated to be epidemiologically associated with
asthma in at least two ways. They may initiate the devel-
opment of the atopic state in infants and children. Further,
they cause acute exacerbations in children with established
asthma. RSV and parainfluenza, with their tendency to
cause bronchiolitis in infants, have been most intensively
studied (19). Recently rhinoviruses have also been recog-
nized as a principal trigger of asthma exacerbation in older
children and adults (20). Our data indicate that HMPVmay
also be important in this regard, and its role in the patho-
genesis of wheezing in the younger child, as well as the
mechanism by which it produces asthma symptoms, war-
rants further study. Elucidation of the roles of cytokines
and chemokines in asthma attacks associated with viral
infections, such as HMPV, will have implications for the
rational use of anti-inflammatory agents such as corticos-
teroids and leukotriene receptor antagonists.
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